3/28
10:46 am
dxr
Daxor Corporation (NASDAQ:DXR) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Daxor Corporation (NASDAQ:DXR) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/25
08:45 am
dxr
Daxor acquires Volumex and Megatope from existing supplier [Seeking Alpha]
Medium
Report
Daxor acquires Volumex and Megatope from existing supplier [Seeking Alpha]
3/25
08:06 am
dxr
Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics [Yahoo! Finance]
Medium
Report
Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics [Yahoo! Finance]
3/25
08:00 am
dxr
Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics
Medium
Report
Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics
3/22
08:18 am
dxr
Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024 [Yahoo! Finance]
Low
Report
Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024 [Yahoo! Finance]
3/22
08:00 am
dxr
Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024
Low
Report
Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024
3/18
02:29 pm
dxr
Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023 [Yahoo! Finance]
Low
Report
Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023 [Yahoo! Finance]
3/18
02:29 pm
dxr
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders [Yahoo! Finance]
Low
Report
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders [Yahoo! Finance]
3/18
02:18 pm
dxr
Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023
Low
Report
Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023
3/18
02:18 pm
dxr
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
Low
Report
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
3/11
08:16 am
dxr
Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User Base [Yahoo! Finance]
Medium
Report
Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User Base [Yahoo! Finance]
3/11
08:00 am
dxr
Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User Base
Medium
Report
Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User Base
3/8
08:12 am
dxr
Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor's Unique Clinical Utility for Heart Failure Patients [Yahoo! Finance]
High
Report
Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor's Unique Clinical Utility for Heart Failure Patients [Yahoo! Finance]
3/8
08:00 am
dxr
Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor’s Unique Clinical Utility for Heart Failure Patients
High
Report
Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor’s Unique Clinical Utility for Heart Failure Patients
2/26
08:18 am
dxr
Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference [Yahoo! Finance]
Low
Report
Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference [Yahoo! Finance]
2/26
08:00 am
dxr
Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference
Low
Report
Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference
2/12
08:04 am
dxr
Daxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer Acquisitions [Yahoo! Finance]
Neutral
Report
Daxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer Acquisitions [Yahoo! Finance]
2/12
08:00 am
dxr
Daxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer Acquisitions
Neutral
Report
Daxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer Acquisitions
2/7
08:17 am
dxr
Daxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100® Blood Volume Diagnostic Across the U.S. at Existing Accounts [Yahoo! Finance]
Low
Report
Daxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100® Blood Volume Diagnostic Across the U.S. at Existing Accounts [Yahoo! Finance]
2/7
08:00 am
dxr
Daxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100® Blood Volume Diagnostic Across the U.S. at Existing Accounts
Low
Report
Daxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100® Blood Volume Diagnostic Across the U.S. at Existing Accounts
1/29
08:09 am
dxr
Daxor Corporation to Exhibit at the Society of Nuclear Medicine and Molecular Imaging Mid-Winter and American College Nuclear Medicine Annual Meeting [Yahoo! Finance]
Low
Report
Daxor Corporation to Exhibit at the Society of Nuclear Medicine and Molecular Imaging Mid-Winter and American College Nuclear Medicine Annual Meeting [Yahoo! Finance]
1/29
08:00 am
dxr
Daxor Corporation to Exhibit at the Society of Nuclear Medicine and Molecular Imaging Mid-Winter and American College Nuclear Medicine Annual Meeting
Low
Report
Daxor Corporation to Exhibit at the Society of Nuclear Medicine and Molecular Imaging Mid-Winter and American College Nuclear Medicine Annual Meeting
1/16
08:09 am
dxr
Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2024 Critical Care Congress [Yahoo! Finance]
Low
Report
Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2024 Critical Care Congress [Yahoo! Finance]
1/16
08:00 am
dxr
Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2024 Critical Care Congress
Low
Report
Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2024 Critical Care Congress
1/9
08:10 am
dxr
DAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMES [Yahoo! Finance]
Low
Report
DAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMES [Yahoo! Finance]